Comparative prognostic value of hemoglobin glycation index and glycation gap for mortality risk in adults: A

Xiaoying Sun1, Ping Yu1, Chun Zhang2

  • 1Department of Endocrinology, Huzhou Third Municipal Hospital, The Affiliated Hospital of Huzhou University, Huzhou, China.

PubMed

Insights

The hemoglobin glycation index (HGI) and glycation gap (GG) can help predict mortality risk. Combined assessment of HGI and GG aids in identifying individuals at higher risk for cardiovascular disease (CVD) and all-cause mortality.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Hemoglobin A1c (HbA1c) is a standard diabetes marker, but individual glycation levels vary.
  • Hemoglobin glycation index (HGI) and glycation gap (GG) quantify this discordance.
  • These markers may offer insights beyond HbA1c alone.

Purpose of the Study:

  • To compare the predictive capabilities of HGI and GG for all-cause and cardiovascular disease (CVD) mortality.
  • To assess the utility of HGI and GG in a nationally representative adult population.
  • To evaluate the combined predictive value of HGI and GG.

Main Methods:

  • Utilized data from 3468 adults in the US National Health and Nutrition Examination Survey (1999-2004).
  • Stratified participants based on median absolute values of HGI and GG.
  • Employed Cox proportional hazard models and time-dependent receiver-operating characteristic (ROC) curves to analyze associations with mortality.

Main Results:

  • Over a median follow-up of 101 months, 733 (12.48%) deaths occurred, including 210 from CVD.
  • The HGI+/GG+ group showed significantly higher hazard ratios for all-cause (1.36) and CVD mortality (1.91) compared to the HGI-/GG- group.
  • Both HGI and GG demonstrated comparable predictive accuracy (AUC 0.50-0.60) with a linear relationship to mortality risk.

Conclusions:

  • HGI and GG are valuable markers for predicting mortality risk, particularly CVD mortality.
  • Combined assessment of HGI and GG enhances risk stratification and identification of high-risk individuals.
  • These glycation markers provide additional prognostic information beyond standard HbA1c measurements.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
772
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
533